235 related articles for article (PubMed ID: 16177326)
1. Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia.
Marcato P; Griener TP; Mulvey GL; Armstrong GD
Infect Immun; 2005 Oct; 73(10):6523-9. PubMed ID: 16177326
[TBL] [Abstract][Full Text] [Related]
2. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit.
Marcato P; Mulvey G; Read RJ; Vander Helm K ; Nation PN; Armstrong GD
J Infect Dis; 2001 Feb; 183(3):435-43. PubMed ID: 11133375
[TBL] [Abstract][Full Text] [Related]
3. Large-scale preparation of Shiga toxin 2 in Escherichia coli for toxoid vaccine antigen production.
Arimitsu H; Sasaki K; Shimizu T; Tsukamoto K; Shimizu T; Tsuji T
Microbiol Immunol; 2013 Jan; 57(1):38-45. PubMed ID: 23157558
[TBL] [Abstract][Full Text] [Related]
4. Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice.
Gu J; Liu Y; Yu S; Wang H; Wang Q; Yi Y; Zhu F; Yu XJ; Zou Q; Mao X
Microbes Infect; 2009 Sep; 11(10-11):835-41. PubMed ID: 19427397
[TBL] [Abstract][Full Text] [Related]
5. Immunization with a chimera consisting of the B subunit of Shiga toxin type 2 and brucella lumazine synthase confers total protection against Shiga toxins in mice.
Mejias MP; Ghersi G; Craig PO; Panek CA; Bentancor LV; Baschkier A; Goldbaum FA; Zylberman V; Palermo MS
J Immunol; 2013 Sep; 191(5):2403-11. PubMed ID: 23918978
[TBL] [Abstract][Full Text] [Related]
6. Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection.
Cai K; Gao X; Li T; Wang Q; Hou X; Tu W; Xiao L; Tian M; Liu Y; Wang H
Vaccine; 2011 Jan; 29(5):946-52. PubMed ID: 21134452
[TBL] [Abstract][Full Text] [Related]
7. A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2.
Tsuji T; Shimizu T; Sasaki K; Tsukamoto K; Arimitsu H; Ochi S; Shimizu T; Taniguchi K; Noda M; Neri P; Mori H
Vaccine; 2008 Apr; 26(17):2092-9. PubMed ID: 18387720
[TBL] [Abstract][Full Text] [Related]
8. B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: a novel peptide vaccine candidate.
Wan CS; Zhou Y; Yu Y; Peng LJ; Zhao W; Zheng XL
Microbiol Immunol; 2011 Apr; 55(4):247-53. PubMed ID: 21272063
[TBL] [Abstract][Full Text] [Related]
9. The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli.
Shimizu T; Kawakami S; Sato T; Sasaki T; Higashide M; Hamabata T; Ohta T; Noda M
Infect Immun; 2007 May; 75(5):2189-200. PubMed ID: 17325057
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice.
Gu J; Ning Y; Wang H; Xiao D; Tang B; Luo P; Cheng Y; Jiang M; Li N; Zou Q; Mao X
Vaccine; 2011 Oct; 29(43):7395-403. PubMed ID: 21807051
[TBL] [Abstract][Full Text] [Related]
11. Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins.
Liu J; Sun Y; Feng S; Zhu L; Guo X; Qi C
Vaccine; 2009 Oct; 27(43):5929-35. PubMed ID: 19682616
[TBL] [Abstract][Full Text] [Related]
12. Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.
Rojas RL; Gomes PA; Bentancor LV; Sbrogio-Almeida ME; Costa SO; Massis LM; Ferreira RC; Palermo MS; Ferreira LC
Clin Vaccine Immunol; 2010 Apr; 17(4):529-36. PubMed ID: 20147499
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of monoclonal antibodies against Shiga toxin 2 and their application for toxin detection in milk.
He X; McMahon S; Skinner C; Merrill P; Scotcher MC; Stanker LH
J Immunol Methods; 2013 Mar; 389(1-2):18-28. PubMed ID: 23279946
[TBL] [Abstract][Full Text] [Related]
14. Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera.
Mejias MP; Cabrera G; Fernández-Brando RJ; Baschkier A; Ghersi G; Abrey-Recalde MJ; Miliwebsky E; Meiss R; Goldbaum F; Zylberman V; Rivas M; Palermo MS
Infect Immun; 2014 Apr; 82(4):1491-9. PubMed ID: 24421050
[TBL] [Abstract][Full Text] [Related]
15. Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B.
Zhu C; Yu J; Yang Z; Davis K; Rios H; Wang B; Glenn G; Boedeker EC
Clin Vaccine Immunol; 2008 Feb; 15(2):359-66. PubMed ID: 18003816
[TBL] [Abstract][Full Text] [Related]
16. Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice.
Gao X; Cai K; Li T; Wang Q; Hou X; Tian R; Liu H; Tu W; Xiao L; Fang L; Luo S; Liu Y; Wang H
Vaccine; 2011 Sep; 29(38):6656-63. PubMed ID: 21742003
[TBL] [Abstract][Full Text] [Related]
17. Immunization with BLS-Stx2B chimera totally protects dams from early pregnancy loss induced by Shiga toxin type 2 (Stx2) and confers anti-Stx2 immunity to the offspring.
Sacerdoti F; Mejías MP; Bruballa AC; Alvarez RS; Amaral MM; Palermo MS; Ibarra C
Vaccine; 2016 Sep; 34(39):4732-4737. PubMed ID: 27527816
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.
Zhang XH; He KW; Zhang SX; Lu WC; Zhao PD; Luan XT; Ye Q; Wen LB; Li B; Guo RL; Wang XM; Lv LX; Zhou JM; Yu ZY; Mao AH
Vaccine; 2011 May; 29(22):3923-9. PubMed ID: 21338683
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.
Sheoran AS; Dmitriev IP; Kashentseva EA; Cohen O; Mukherjee J; Debatis M; Shearer J; Tremblay JM; Beamer G; Curiel DT; Shoemaker CB; Tzipori S
Infect Immun; 2015 Jan; 83(1):286-91. PubMed ID: 25368111
[TBL] [Abstract][Full Text] [Related]
20. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.
Mukherjee J; Chios K; Fishwild D; Hudson D; O'Donnell S; Rich SM; Donohue-Rolfe A; Tzipori S
Infect Immun; 2002 Feb; 70(2):612-9. PubMed ID: 11796590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
